Literature DB >> 8119639

Endoscopic sphincterotomy for acute pancreatitis.

J P Neoptolemos1, P Stonelake, S Radley.   

Abstract

There is now considerable evidence linking the severity of gallstone-associated acute pancreatitis with obstruction to both the bile duct and the pancreatic duct by "persisting" stones either because of continuous or repeated impaction, or repeated passage. Two prospective trials have shown endoscopic sphincterotomy to be superior to other forms of treatment, but only in severe cases, and general experience now extends to over 1000 cases so treated. Endoscopic sphincterotomy is also very effective in acute pancreatitis associated with acute cholangitis. Prophylactic endoscopic sphincterotomy may be of benefit in elderly patients in preference to prophylactic cholecystectomy. Yet to be fully explored is the role of this procedure in the early treatment of severe non-gallstone pancreatitis and in established pancreatic necrosis.

Entities:  

Mesh:

Year:  1993        PMID: 8119639

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Endoscopic sphincterotomy in acute biliary pancreatitis: A question of anesthesiological risk.

Authors:  Raffaele Pezzilli
Journal:  World J Gastrointest Endosc       Date:  2009-10-15

Review 2.  Improving the Outcome of Acute Pancreatitis.

Authors:  Marco J Bruno
Journal:  Dig Dis       Date:  2016-06-23       Impact factor: 2.404

3.  Early biliary decompression versus conservative treatment in acute biliary pancreatitis (APEC trial): study protocol for a randomized controlled trial.

Authors:  Nicolien J Schepers; Olaf J Bakker; Marc G H Besselink; Thomas L Bollen; Marcel G W Dijkgraaf; Casper H J van Eijck; Paul Fockens; Erwin J M van Geenen; Janneke van Grinsven; Nora D L Hallensleben; Bettina E Hansen; Hjalmar C van Santvoort; Robin Timmer; Marie-Paule G F Anten; Clemens J M Bolwerk; Foke van Delft; Hendrik M van Dullemen; G Willemien Erkelens; Jeanin E van Hooft; Robert Laheij; René W M van der Hulst; Jeroen M Jansen; Frank J G M Kubben; Sjoerd D Kuiken; Lars E Perk; Rogier J J de Ridder; Marno C M Rijk; Tessa E H Römkens; Erik J Schoon; Matthijs P Schwartz; B W Marcel Spanier; Adriaan C I T L Tan; Willem J Thijs; Niels G Venneman; Frank P Vleggaar; Wim van de Vrie; Ben J Witteman; Hein G Gooszen; Marco J Bruno
Journal:  Trials       Date:  2016-01-05       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.